Casado MA
Revisión de artículos: Pani L, Becker K. New Models for the Evaluation of Specialized Medicinal Products: Beyond Conventional Health Technology Assessment and Pricing. Clinical Drug Investigation 2021; 41:529-537
NewsRARE 2021; 6: 96-99
Casado MA, Gallardo J
La importancia de la evaluación económica de intervenciones sanitarias, como complemento a la evidencia clínica en España
ZeroLeucemia 2021; 1: 65-66
MÁS INFORMACIÓN
García-Herola A, Domínguez-Hernández R, Casado MA
Clinical and economic impact of an alert system in primary care for the detection of patients with chronic hepatitis C
PLoS One. 2021; 16(12)
Fernández Sanchis D, Cuenca Zaldívar JN, Calvo S, Herrero P, Gómez Barrera M
Cost-effectiveness of upper extremity dry needling in the rehabilitation of patients with stroke
Acupuncture in medicine. DOI: 10.1177/09645284211055750
Marron SE, Gomez-Barrera M, Tomas Aragones L, Goni-Navarro A, Vilarrasa-Rull E, Diaz-Diaz RM
Quality of Life in Hidradenitis Suppurativa: validation of the HSQoL-24
Acta Derm Venereol 2021; 101: adv00529. doi: 10.2340/00015555-3905
Forns X, Colom J, García-Retortillo M, Quer JC, Lens S, Martró E, Domínguez-Hernández R, Casado MA, Buti M
Point-of-care hepatitis C testing and treatment strategy for people attending harm reduction and addiction centres for hepatitis C elimination
J Viral Hepat. 2021;00:1–4
MÁS INFORMACIÓN
Calleja MA, Albanell J, Aranda E, García-Foncillas J, Feliu A, Rivera F, Oyagüez I, Salinas-Ortega L, Soto J
Budget impact analysis of bevacizumab biosimilars for cancer treatment in adult patients in Spain
Eur J Hosp Pharm. doi:10.1136/ejhpharm-2021-002955
Gomez-Peralta F, Mareque M, Muñoz A, Maderuelo M, Casado MA
Patient preferences for pharmacological diabetes treatment among people with diabetes in Spain – A discrete choice experiment
Diabetes Ther. 2022;13(1):75-87
Pascua FS, Muñoz A, Oraa R, Flórez G, Notario P, Seijo P, Gonzalvo B, Assaf C, Gómez M, Casado MA
Perception of a new prolonged-release buprenorphine formulation in patients with opioid use disorder. The PREDEPO study
European Addiction Research: Doi: DOI:10.1159/000520091
Moltó J, González J, Navarro C, Castro A, Presa M, Oyagüez I